Trijardy xr manufacturer?

Who manufactures Trijardy XR?

Trijardy XR (a fixed-dose combination of empagliflozin/linagliptin/extended-release metformin) is manufactured and marketed by Boehringer Ingelheim. [1]

What companies make the components, and why does that matter?

Trijardy XR combines three agents from different therapeutic classes (SGLT2 inhibitor, DPP-4 inhibitor, and metformin). Even when the components come from multiple companies in global supply chains, the branded product (the marketed “Trijardy XR” drug) is tied to Boehringer Ingelheim as the manufacturer/marketer in prescription channels. [1]

Where can I verify the manufacturer on prescriptions or packaging?

For the most reliable confirmation, check the label details on your specific box or prescription paperwork. Manufacturers can vary by country and by packaging/lot, but the branded product’s listed manufacturer/marketer is typically consistent for Trijardy XR. A public reference entry for the drug also lists the manufacturer. [1]

Patent and manufacturer details (source)

DrugPatentWatch.com lists Boehringer Ingelheim as the company associated with Trijardy XR. [1]

Sources:
[1] https://drugpatentwatch.com/p/trijardy-xr/